Heterozygous Mutations of Are Associated with an Increased Risk of Isolated Metopic Craniosynostosis in Humans and Mice

English version České info

The premature fusion of the paired frontal bones results in metopic craniosynostosis (MC) and gives rise to the clinical phenotype of trigonocephaly. Deletions of chromosome 9p22.3 are well described as a cause of MC with variably penetrant midface hypoplasia. In order to identify the gene responsible for the trigonocephaly component of the 9p22.3 syndrome, a cohort of 109 patients were assessed by high-resolution arrays and MLPA for copy number variations (CNVs) involving 9p22. Five CNVs involving FREM1, all of which were de novo variants, were identified by array-based analyses. The remaining 104 patients with MC were then subjected to targeted FREM1 gene re-sequencing, which identified 3 further mutant alleles, one of which was de novo. Consistent with a pathogenic role, mouse Frem1 mRNA and protein expression was demonstrated in the metopic suture as well as in the pericranium and dura mater. Micro-computed tomography based analyses of the mouse posterior frontal (PF) suture, the human metopic suture equivalent, revealed advanced fusion in all mice homozygous for either of two different Frem1 mutant alleles, while heterozygotes exhibited variably penetrant PF suture anomalies. Gene dosage-related penetrance of midfacial hypoplasia was also evident in the Frem1 mutants. These data suggest that CNVs and mutations involving FREM1 can be identified in a significant percentage of people with MC with or without midface hypoplasia. Furthermore, we present Frem1 mutant mice as the first bona fide mouse model of human metopic craniosynostosis and a new model for midfacial hypoplasia.

Vyšlo v časopise: Heterozygous Mutations of Are Associated with an Increased Risk of Isolated Metopic Craniosynostosis in Humans and Mice. PLoS Genet 7(9): e32767. doi:10.1371/journal.pgen.1002278
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002278

Souhrn

Zdroje

1. Gorlin RJCMHennekamRCM 2001 Syndromes of the Head and Neck 1344

2. Passos-BuenoMRSerti EacuteAEJeheeFSFanganielloRYehE 2008 Genetics of craniosynostosis: genes, syndromes, mutations and genotype-phenotype correlations. Front Oral Biol 12 107 143

3. van der MeulenJvan der HulstRvan AdrichemLArnaudEChin-ShongD 2009 The increase of metopic synostosis: a pan-European observation. J Craniofac Surg 20 283 286

4. SingerSBowerCSouthallPGoldblattJ 1999 Craniosynostosis in Western Australia, 1980-1994: a population-based study. Am J Med Genet 83 382 387

5. Di RoccoFArnaudERenierD 2009 Evolution in the frequency of nonsyndromic craniosynostosis. J Neurosurg Pediatr 4 21 25

6. AlfiODonnellGNCrandallBFDerencsenyiAMenonR 1973 Deletion of the short arm of chromosome no.9 (46,9p-): a new deletion syndrome. Ann Genet 16 17 22

7. YoungRSReedTHodesMEPalmerCG 1982 The dermatoglyphic and clinical features of the 9p trisomy and partial 9p monosomy syndromes. Hum Genet 62 31 39

8. YoungRSBaderPPalmerCGKalerSGHodesME 1983 Brief clinical report: two children with de novo del(9p). Am J Med Genet 14 751 757

9. HuretJLLeonardCForestierBRethoreMOLejeuneJ 1988 Eleven new cases of del(9p) and features from 80 cases. J Med Genet 25 741 749

10. HouJW 2003 Del (9p) syndrome: report of four cases. Acta Paediatr Taiwan 44 50 53

11. SwinkelsMESimonsASmeetsDFVissersLEVeltmanJA 2008 Clinical and cytogenetic characterization of 13 Dutch patients with deletion 9p syndrome: Delineation of the critical region for a consensus phenotype. Am J Med Genet A 146A 1430 1438

12. KawaraHYamamotoTHaradaNYoshiuraKNiikawaN 2006 Narrowing candidate region for monosomy 9p syndrome to a 4.7-Mb segment at 9p22.2-p23. Am J Med Genet A 140 373 377

13. JeheeFSAlonsoLGCavalcantiDPKimCWallSA 2006 Mutational screening of FGFR1, CER1, and CDON in a large cohort of trigonocephalic patients. Cleft Palate Craniofac J 43 148 151

14. HaradaMMurakamiHOkawaAOkimotoNHiraokaS 2009 FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion. Nat Genet 41 289 298

15. AlazamiAMShaheenRAlzahraniFSnapeKSaggarA 2009 FREM1 mutations cause bifid nose, renal agenesis, and anorectal malformations syndrome. Am J Hum Genet 85 414 418

16. SlavotinekAMBaranziniSESchanzeDLabelle-DumaisCShortKM 2011 Manitoba-oculo-tricho-anal (MOTA) syndrome is caused by mutations in FREM1. J Med Genet 48 375 382

17. GranthamR 1974 Amino acid difference formula to help explain protein evolution. Science 185 862 864

18. NgPCHenikoffS 2003 SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31 3812 3814

19. SunyaevSRamenskyVKochILatheW3rdKondrashovAS 2001 Prediction of deleterious human alleles. Hum Mol Genet 10 591 597

20. PollardKSHubiszMJRosenbloomKRSiepelA Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 20 110 121

21. SmythIDuXTaylorMSJusticeMJBeutlerB 2004 The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. Proc Natl Acad Sci U S A 101 13560 13565

22. GoretzkiLBurgMAGrakoKAStallcupWB 1999 High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J Biol Chem 274 16831 16837

23. DalgleishR 1998 The Human Collagen Mutation Database 1998. Nucleic Acids Res 26 253 255

24. LiuWSchrijverIBrennTFurthmayrHFranckeU 2001 Multi-exon deletions of the FBN1 gene in Marfan syndrome. BMC Med Genet 2 11

25. GoldsteinJLBrownMS 2009 The LDL receptor. Arterioscler Thromb Vasc Biol 29 431 438

26. ArighiEBorrelloMGSariolaH 2005 RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev 16 441 467

27. GarinIEdghillELAkermanIRubio-CabezasORicaI Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis. Proc Natl Acad Sci U S A 107 3105 3110

28. KiyozumiDSugimotoNSekiguchiK 2006 Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects. Proc Natl Acad Sci U S A 103 11981 11986

29. VarnumDSFoxSC 1981 Head blebs: a new mutation on chromosome 4 of the mouse. J Hered 72 293

30. KanSHElankoNJohnsonDCornejo-RoldanLCookJ 2002 Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet 70 472 486

31. IngersollRGPaznekasWATranAKScottAFJiangG 2001 Fibroblast growth factor receptor 2 (FGFR2): genomic sequence and variations. Cytogenet Cell Genet 94 121 126

32. SchoutenJPMcElgunnCJWaaijerRZwijnenburgDDiepvensF 2002 Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30 e57

33. MillPLeeAWFukataYTsutsumiRFukataM 2009 Palmitoylation regulates epidermal homeostasis and hair follicle differentiation. PLoS Genet 5 e1000748

34. Steele-PerkinsGPlachezCButzKGYangGBachurskiCJ 2005 The transcription factor gene Nfib is essential for both lung maturation and brain development. Mol Cell Biol 25 685 698

35. AsheAMorganDKWhitelawNCBruxnerTJVickaryousNK 2008 A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development. Genome Biol 9 R182

36. Kaminen-AholaNAholaAMagaMMallittKAFaheyP 2010 Maternal ethanol consumption alters the epigenotype and the phenotype of offspring in a mouse model. PLoS Genet 6 e1000811

37. Dryden 2009 Shapes: Statistical shape analysis. R package version 1.1-3

38. PetrouPChiotakiRDaleziosYChalepakisG 2007 Overlapping and divergent localization of Frem1 and Fras1 and its functional implications during mouse embryonic development. Exp Cell Res 313 910 920